Measures of heart rate variability (HRV) as a predictor of risk of disease and mortality have
been investigated from various perspectives for more than six decades. The aim of the …

The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase
due to the diabetes epidemic and its early and widespread appearance. CAN has a definite …

Lower heart rate variability (HRV) is associated with a higher risk of cardiovascular events
and mortality, although the extent of the association is uncertain. We performed a meta …

Autonomic nervous system (ANS) imbalance manifesting as cardiac autonomic neuropathy
in the diabetic population is an important predictor of cardiovascular events. Symptoms and …

Cardiac autonomic neuropathy (CAN) is a major complication of type 1 and type 2 diabetes
mellitus (T1DM and T2DM). The increased morbidity, cardiovascular and all-cause mortality …

Abstract Study Objectives Short sleep duration and poor sleep quality are associated with
adverse cardiovascular outcomes. Potential pathophysiological mechanisms include sleep …

We aimed to determine the prognostic association between cardiac autonomic neuropathy
(CAN) and cardiovascular disease events (CVE) and mortality in type 1 and type 2 diabetes …

Fibromyalgia (FM) syndrome is a common illness characterized by chronic widespread pain,
sleep problems, fatigue, and cognitive difficulties. Dysfunctional neurotransmitter systems …

Aims/hypothesis Cardiac autonomic neuropathy (CAN) is independently associated with
silent myocardial ischaemia, major cardiovascular events, myocardial dysfunction and …

Sudorimetry technology has evolved dramatically, as a rapid, non-invasive, robust, and
accurate biomarker for small fibers that can easily be integrated into clinical practice …